BOSTON (Reuters) - The U.S. Food and Drug Administration on Friday took steps to restrict what pharmaceutical ingredients large compounding pharmacies can use to manufacture drugs in bulk that do not ...

The Guidance Notice indicates that the Draft Guidance provides information on the application of the Federal Food, Drug, and Cosmetic Act (FFDCA) to compounded animal drug products. Specifically, the ...

WASHINGTON, Oct. 26-- Shawn Hodges, president with the Alexandria, Virginia-based Alliance for Pharmacy Compounding, has issued a public comment on the Food and Drug Administration notice entitled ...

(CN) - The Food and Drug Administration cannot bar a Florida pharmacy from using bulk active ingredients to compound drugs for animals that don't produce food, a federal judge ruled. Ocala-based ...

On May 18, 2015, FDA released new draft guidance on animal drug compounding from bulk drug substances. While FDA’s current statutory framework and regulations do not permit compounding of animal drugs ...

Agency Planning Outreach and Education Period as Part of Implementation SILVER SPRING, Md., April 13, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration issued a final guidance, ...

The FDA included quinacrine hydrochloride to its list of bulk drug substances allowed to be used in compounding by outsourcing facilities on April 6. It is the fifth addition and is for oral use only.

Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. Performing calculations for the formulation of pharmaceutical dosage forms and ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, the FDA announced that all doses of Novo Nordisk’s Ozempic and Wegovy ...